SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1v5f'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C6Y_B_MK1B524_1
(PROTEIN (PROTEASE))
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 11 LEU A 276
ALA A 214
VAL A 236
GLY A 222
ILE A 212
None
0.86A 1c6yA-1v5fA:
undetectable
1c6yA-1v5fA:
10.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C6Y_B_MK1B524_2
(PROTEIN (PROTEASE))
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.91A 1c6yB-1v5fA:
undetectable
1c6yB-1v5fA:
10.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C6Z_B_ROCB505_1
(PROTEIN (PROTEASE))
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.94A 1c6zA-1v5fA:
undetectable
1c6zA-1v5fA:
10.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1E06_B_IPBB600_0
(ODORANT-BINDING
PROTEIN)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
4 / 4 ILE A 102
MET A  36
VAL A  51
GLY A 104
None
1.29A 1e06B-1v5fA:
undetectable
1e06B-1v5fA:
13.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HPV_B_478B200_2
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 9 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.91A 1hpvB-1v5fA:
undetectable
1hpvB-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HSG_B_MK1B902_1
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 10 LEU A 276
ALA A 214
VAL A 236
GLY A 222
ILE A 212
None
0.85A 1hsgA-1v5fA:
undetectable
1hsgA-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HSG_B_MK1B902_2
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.89A 1hsgB-1v5fA:
undetectable
1hsgB-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HVY_D_D16D417_1
(THYMIDYLATE SYNTHASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ILE A  97
LEU A  89
LEU A  71
GLY A  72
ALA A 148
None
1.11A 1hvyD-1v5fA:
undetectable
1hvyD-1v5fA:
17.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HXB_A_ROCA100_3
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.89A 1hxbB-1v5fA:
undetectable
1hxbB-1v5fA:
11.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HXW_B_RITB301_2
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 11 GLY A 390
ASP A 442
VAL A 466
GLY A 418
ILE A 419
TPP  A1602 ( 3.9A)
MG  A1603 ( 2.8A)
None
None
None
0.92A 1hxwB-1v5fA:
undetectable
1hxwB-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ICU_C_NIOC225_1
(OXYGEN-INSENSITIVE
NAD(P)H
NITROREDUCTASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
4 / 6 SER A  77
PHE A  48
GLU A  54
GLY A  26
None
1.11A 1icuC-1v5fA:
undetectable
1icuD-1v5fA:
undetectable
1icuC-1v5fA:
16.41
1icuD-1v5fA:
16.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1K6C_B_MK1B902_2
(POL POLYPROTEIN)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 GLY A 390
ASP A 442
VAL A 466
GLY A 418
ILE A 419
TPP  A1602 ( 3.9A)
MG  A1603 ( 2.8A)
None
None
None
0.98A 1k6cB-1v5fA:
undetectable
1k6cB-1v5fA:
10.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1KIA_C_SAMC2293_0
(GLYCINE
N-METHYLTRANSFERASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ILE A 387
GLY A 423
ALA A  61
GLY A 418
LEU A  85
None
1.04A 1kiaC-1v5fA:
3.2
1kiaC-1v5fA:
19.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QVU_A_PRLA196_0
(TRANSCRIPTIONAL
REGULATOR QACR)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
4 / 6 LEU A 550
GLU A 548
THR A 395
TYR A 565
None
1.45A 1qvuA-1v5fA:
1.2
1qvuA-1v5fA:
15.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RB3_A_MTXA161_1
(DIHYDROFOLATE
REDUCTASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 10 ILE A 300
ALA A 214
LEU A 228
ILE A 298
THR A 218
None
1.26A 1rb3A-1v5fA:
undetectable
1rb3A-1v5fA:
16.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RE7_A_FOLA161_0
(DIHYDROFOLATE
REDUCTASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ILE A 300
ALA A 214
LEU A 228
ILE A 298
THR A 218
None
1.12A 1re7A-1v5fA:
undetectable
1re7A-1v5fA:
16.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RL8_A_RITA9001_1
(PROTEASE RETROPEPSIN)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.88A 1rl8A-1v5fA:
undetectable
1rl8A-1v5fA:
10.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SDT_B_MK1B902_2
(PROTEASE RETROPEPSIN)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.93A 1sdtB-1v5fA:
undetectable
1sdtB-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1T3R_A_017A1200_2
(PROTEASE RETROPEPSIN)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 11 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.85A 1t3rB-1v5fA:
undetectable
1t3rB-1v5fA:
10.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XZX_X_T3X500_2
(THYROID HORMONE
RECEPTOR BETA-1)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
3 / 3 PHE A 282
ARG A 409
ASN A 242
FAD  A1601 (-4.1A)
None
None
0.92A 1xzxX-1v5fA:
undetectable
1xzxX-1v5fA:
18.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A1M_A_CAMA1422_0
(CYTOCHROME P450-CAM)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
4 / 7 THR A 448
VAL A 466
GLY A 441
THR A 393
None
None
TPP  A1602 (-3.6A)
None
0.96A 2a1mA-1v5fA:
undetectable
2a1mA-1v5fA:
19.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2AQU_B_DR7B300_1
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 10 ALA A 324
ASP A 320
GLY A 279
VAL A 315
ILE A 317
None
FAD  A1601 (-3.8A)
FAD  A1601 (-3.5A)
None
None
0.99A 2aquA-1v5fA:
undetectable
2aquA-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2AVS_B_MK1B902_1
(POL POLYPROTEIN)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.87A 2avsA-1v5fA:
undetectable
2avsA-1v5fA:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2AVS_B_MK1B902_3
(POL POLYPROTEIN)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.89A 2avsB-1v5fA:
undetectable
2avsB-1v5fA:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2B25_A_SAMA601_0
(HYPOTHETICAL PROTEIN)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 THR A 239
GLY A 217
GLY A 215
ASP A 303
ILE A 302
FAD  A1601 (-2.8A)
FAD  A1601 (-3.4A)
FAD  A1601 (-2.9A)
None
FAD  A1601 (-3.9A)
1.04A 2b25A-1v5fA:
undetectable
2b25A-1v5fA:
21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2B25_B_SAMB602_0
(HYPOTHETICAL PROTEIN)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 THR A 239
SER A 280
GLY A 279
ASP A  91
ILE A  97
FAD  A1601 (-2.8A)
FAD  A1601 (-2.6A)
FAD  A1601 (-3.5A)
None
None
1.10A 2b25B-1v5fA:
undetectable
2b25B-1v5fA:
21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2F81_A_017A302_1
(POL POLYPROTEIN)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
1.00A 2f81A-1v5fA:
undetectable
2f81A-1v5fA:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2F81_A_017A302_2
(POL POLYPROTEIN)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.97A 2f81B-1v5fA:
undetectable
2f81B-1v5fA:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2F8G_B_017B401_1
(POL POLYPROTEIN)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.93A 2f8gA-1v5fA:
undetectable
2f8gA-1v5fA:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2F8G_B_017B401_2
(POL POLYPROTEIN)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
6 / 12 LEU A 276
GLY A 215
ALA A 214
VAL A 236
GLY A 222
ILE A 212
None
FAD  A1601 (-2.9A)
None
None
None
None
1.26A 2f8gB-1v5fA:
undetectable
2f8gB-1v5fA:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IDW_B_017B401_1
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 11 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.97A 2idwA-1v5fA:
undetectable
2idwA-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IEN_B_017B402_1
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
6 / 12 LEU A 276
GLY A 215
ALA A 214
VAL A 236
GLY A 222
ILE A 212
None
FAD  A1601 (-2.9A)
None
None
None
None
1.26A 2ienA-1v5fA:
undetectable
2ienA-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IEN_B_017B402_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.89A 2ienB-1v5fA:
undetectable
2ienB-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IEN_B_017B402_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 GLY A 390
ASP A 442
VAL A 466
GLY A 418
ILE A 419
TPP  A1602 ( 3.9A)
MG  A1603 ( 2.8A)
None
None
None
0.85A 2ienB-1v5fA:
undetectable
2ienB-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IEO_A_017A402_1
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 GLY A 390
ASP A 442
VAL A 466
GLY A 418
ILE A 419
TPP  A1602 ( 3.9A)
MG  A1603 ( 2.8A)
None
None
None
0.92A 2ieoA-1v5fA:
undetectable
2ieoA-1v5fA:
9.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IJ7_A_TPFA2472_1
(CYTOCHROME P450 121)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 11 ASN A 344
THR A 268
ALA A 265
SER A 256
PHE A 243
None
None
None
FAD  A1601 ( 4.6A)
None
1.49A 2ij7A-1v5fA:
0.0
2ij7A-1v5fA:
21.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKJ_D_CLMD1142_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
4 / 5 PRO A 189
PRO A 192
ILE A 317
GLY A 319
None
1.05A 2jkjD-1v5fA:
undetectable
2jkjD-1v5fA:
13.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKJ_F_CLMF1143_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
4 / 5 PRO A 189
PRO A 192
ILE A 317
GLY A 319
None
1.06A 2jkjF-1v5fA:
undetectable
2jkjF-1v5fA:
13.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2O4P_A_TPVA300_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 9 LEU A 276
ALA A 214
VAL A 236
GLY A 222
ILE A 212
None
0.93A 2o4pB-1v5fA:
undetectable
2o4pB-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2O4S_A_AB1A400_1
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.96A 2o4sA-1v5fA:
undetectable
2o4sA-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q5K_A_AB1A201_1
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 9 ALA A 324
ASP A 320
GLY A 279
VAL A 315
ILE A 317
None
FAD  A1601 (-3.8A)
FAD  A1601 (-3.5A)
None
None
0.97A 2q5kA-1v5fA:
undetectable
2q5kA-1v5fA:
10.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QHC_B_AB1B9001_1
(PROTEASE RETROPEPSIN)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 11 ALA A 324
ASP A 320
GLY A 279
VAL A 315
ILE A 317
None
FAD  A1601 (-3.8A)
FAD  A1601 (-3.5A)
None
None
0.98A 2qhcA-1v5fA:
undetectable
2qhcA-1v5fA:
10.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QHC_B_AB1B9001_1
(PROTEASE RETROPEPSIN)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 11 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.83A 2qhcA-1v5fA:
undetectable
2qhcA-1v5fA:
10.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QHC_B_AB1B9001_2
(PROTEASE RETROPEPSIN)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.88A 2qhcB-1v5fA:
undetectable
2qhcB-1v5fA:
10.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QHF_A_ACTA502_0
(CHORISMATE SYNTHASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
3 / 3 GLY A 165
ASP A 166
SER A  34
None
0.53A 2qhfA-1v5fA:
undetectable
2qhfA-1v5fA:
22.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WD9_C_IBPC1570_1
(ACYL-COENZYME A
SYNTHETASE ACSM2A,
MITOCHONDRIAL)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 10 THR A 290
ILE A 237
GLY A 215
GLY A 240
THR A 257
None
None
FAD  A1601 (-2.9A)
FAD  A1601 (-3.6A)
None
1.28A 2wd9C-1v5fA:
5.2
2wd9C-1v5fA:
23.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Z54_A_AB1A200_1
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.88A 2z54A-1v5fA:
undetectable
2z54A-1v5fA:
10.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Z54_A_AB1A200_2
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.92A 2z54B-1v5fA:
undetectable
2z54B-1v5fA:
10.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ARU_A_PNXA607_1
(CHITINASE A)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
4 / 8 VAL A 225
GLY A 217
THR A 218
ALA A 321
None
FAD  A1601 (-3.4A)
None
FAD  A1601 (-3.5A)
0.69A 3aruA-1v5fA:
undetectable
3aruA-1v5fA:
23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CYW_A_017A201_1
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.91A 3cywA-1v5fA:
undetectable
3cywA-1v5fA:
11.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CYW_A_017A201_2
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.93A 3cywB-1v5fA:
undetectable
3cywB-1v5fA:
11.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3D1Z_B_017B201_2
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.95A 3d1zB-1v5fA:
undetectable
3d1zB-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3D20_A_017A201_1
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.99A 3d20A-1v5fA:
undetectable
3d20A-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3D20_A_017A201_1
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 GLY A 390
ASP A 442
VAL A 466
GLY A 418
ILE A 419
TPP  A1602 ( 3.9A)
MG  A1603 ( 2.8A)
None
None
None
1.01A 3d20A-1v5fA:
undetectable
3d20A-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EKP_B_478B200_1
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
6 / 8 LEU A 276
GLY A 215
ALA A 214
VAL A 236
GLY A 222
ILE A 212
None
FAD  A1601 (-2.9A)
None
None
None
None
1.25A 3ekpA-1v5fA:
undetectable
3ekpA-1v5fA:
10.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EKP_B_478B200_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 10 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.94A 3ekpB-1v5fA:
undetectable
3ekpB-1v5fA:
10.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EKP_B_478B200_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 10 LEU A 276
ALA A 214
VAL A 236
GLY A 222
ILE A 212
None
0.93A 3ekpB-1v5fA:
undetectable
3ekpB-1v5fA:
10.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EKP_C_478C200_1
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 10 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
1.01A 3ekpC-1v5fA:
undetectable
3ekpC-1v5fA:
10.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EKP_C_478C200_1
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 10 LEU A 276
ALA A 214
VAL A 236
GLY A 222
ILE A 212
None
0.90A 3ekpC-1v5fA:
undetectable
3ekpC-1v5fA:
10.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EKT_B_017B200_1
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 9 GLY A 390
ASP A 442
VAL A 466
GLY A 418
ILE A 419
TPP  A1602 ( 3.9A)
MG  A1603 ( 2.8A)
None
None
None
1.02A 3ektA-1v5fA:
undetectable
3ektA-1v5fA:
10.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EKT_B_017B200_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 9 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.98A 3ektB-1v5fA:
undetectable
3ektB-1v5fA:
10.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EKT_D_017D200_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 11 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.96A 3ektD-1v5fA:
undetectable
3ektD-1v5fA:
10.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EKT_D_017D200_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 11 GLY A 390
ASP A 442
VAL A 466
GLY A 418
ILE A 419
TPP  A1602 ( 3.9A)
MG  A1603 ( 2.8A)
None
None
None
0.97A 3ektD-1v5fA:
undetectable
3ektD-1v5fA:
10.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EKV_A_478A200_1
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
6 / 10 LEU A 276
GLY A 215
ALA A 214
VAL A 236
GLY A 222
ILE A 212
None
FAD  A1601 (-2.9A)
None
None
None
None
1.29A 3ekvA-1v5fA:
undetectable
3ekvA-1v5fA:
10.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EKV_A_478A200_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 9 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.84A 3ekvB-1v5fA:
undetectable
3ekvB-1v5fA:
10.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EKX_B_1UNB201_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 11 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.89A 3ekxB-1v5fA:
undetectable
3ekxB-1v5fA:
10.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EKY_A_DR7A100_1
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 10 ALA A 324
ASP A 320
GLY A 279
VAL A 315
ILE A 317
None
FAD  A1601 (-3.8A)
FAD  A1601 (-3.5A)
None
None
0.97A 3ekyA-1v5fA:
undetectable
3ekyA-1v5fA:
10.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EM3_B_478B200_1
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 10 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.88A 3em3A-1v5fA:
undetectable
3em3A-1v5fA:
10.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EM3_B_478B200_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 10 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.88A 3em3B-1v5fA:
undetectable
3em3B-1v5fA:
10.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EM3_B_478B200_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 10 LEU A 276
ALA A 214
VAL A 236
GLY A 222
ILE A 212
None
0.92A 3em3B-1v5fA:
undetectable
3em3B-1v5fA:
10.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EM4_A_DR7A100_1
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 11 ALA A 324
ASP A 320
GLY A 279
VAL A 315
ILE A 317
None
FAD  A1601 (-3.8A)
FAD  A1601 (-3.5A)
None
None
0.95A 3em4A-1v5fA:
undetectable
3em4A-1v5fA:
10.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EM4_A_DR7A100_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 9 ALA A 324
ASP A 320
GLY A 279
VAL A 315
ILE A 317
None
FAD  A1601 (-3.8A)
FAD  A1601 (-3.5A)
None
None
0.99A 3em4B-1v5fA:
undetectable
3em4B-1v5fA:
10.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EM6_A_017A200_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.89A 3em6B-1v5fA:
undetectable
3em6B-1v5fA:
10.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JVY_B_017B401_1
(GAG-POL POLYPROTEIN)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.84A 3jvyA-1v5fA:
undetectable
3jvyA-1v5fA:
9.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K4V_D_ROCD201_1
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.91A 3k4vC-1v5fA:
undetectable
3k4vC-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LSL_A_PZIA801_0
(GLUTAMATE RECEPTOR 2)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
4 / 8 ILE A 419
PRO A 422
GLY A 418
ASN A  87
None
None
None
TPP  A1602 ( 4.8A)
0.83A 3lslA-1v5fA:
2.3
3lslD-1v5fA:
undetectable
3lslA-1v5fA:
19.06
3lslD-1v5fA:
19.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LSL_D_PZID801_0
(GLUTAMATE RECEPTOR 2)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
4 / 8 ASN A  87
ILE A 419
PRO A 422
GLY A 418
TPP  A1602 ( 4.8A)
None
None
None
0.85A 3lslA-1v5fA:
2.3
3lslD-1v5fA:
undetectable
3lslA-1v5fA:
19.06
3lslD-1v5fA:
19.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LZS_A_017A200_1
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.89A 3lzsA-1v5fA:
undetectable
3lzsA-1v5fA:
11.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LZS_A_017A200_2
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.93A 3lzsB-1v5fA:
undetectable
3lzsB-1v5fA:
11.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LZU_A_017A200_1
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.95A 3lzuA-1v5fA:
undetectable
3lzuA-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LZU_A_017A200_2
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.87A 3lzuB-1v5fA:
undetectable
3lzuB-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LZU_A_017A200_2
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
6 / 12 LEU A 276
GLY A 215
ALA A 214
VAL A 236
GLY A 222
ILE A 212
None
FAD  A1601 (-2.9A)
None
None
None
None
1.29A 3lzuB-1v5fA:
undetectable
3lzuB-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MWS_B_017B201_1
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.83A 3mwsA-1v5fA:
undetectable
3mwsA-1v5fA:
10.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MWS_B_017B201_1
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 GLY A 390
ASP A 442
VAL A 466
GLY A 418
ILE A 419
TPP  A1602 ( 3.9A)
MG  A1603 ( 2.8A)
None
None
None
0.86A 3mwsA-1v5fA:
undetectable
3mwsA-1v5fA:
10.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MWS_B_017B201_2
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.97A 3mwsB-1v5fA:
undetectable
3mwsB-1v5fA:
10.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NDT_D_ROCD100_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.94A 3ndtD-1v5fA:
undetectable
3ndtD-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NDW_A_RITA100_1
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.88A 3ndwA-1v5fA:
undetectable
3ndwA-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NDW_A_RITA100_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 9 ALA A 324
ASP A 320
GLY A 279
VAL A 315
ILE A 317
None
FAD  A1601 (-3.8A)
FAD  A1601 (-3.5A)
None
None
0.95A 3ndwB-1v5fA:
undetectable
3ndwB-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NU5_B_478B401_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.96A 3nu5B-1v5fA:
undetectable
3nu5B-1v5fA:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NU6_B_478B401_1
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 10 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.91A 3nu6A-1v5fA:
undetectable
3nu6A-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NU6_B_478B401_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 10 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.95A 3nu6B-1v5fA:
undetectable
3nu6B-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NUJ_B_478B401_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 9 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.93A 3nujB-1v5fA:
undetectable
3nujB-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NUO_B_478B478_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 9 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.92A 3nuoB-1v5fA:
undetectable
3nuoB-1v5fA:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OU7_B_SAMB300_1
(SAM-DEPENDENT
METHYLTRANSFERASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
3 / 3 TYR A 472
ASP A 442
ASP A 388
TPP  A1602 ( 4.3A)
MG  A1603 ( 2.8A)
None
0.99A 3ou7B-1v5fA:
undetectable
3ou7B-1v5fA:
16.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OU7_C_SAMC300_0
(SAM-DEPENDENT
METHYLTRANSFERASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 LEU A  32
ALA A 101
GLY A  76
LEU A 103
ALA A 159
None
1.34A 3ou7C-1v5fA:
undetectable
3ou7C-1v5fA:
16.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OXC_A_ROCA401_1
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.89A 3oxcA-1v5fA:
undetectable
3oxcA-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OXV_C_478C200_1
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 9 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.88A 3oxvC-1v5fA:
undetectable
3oxvC-1v5fA:
10.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OXV_C_478C200_1
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 9 LEU A 276
ALA A 214
VAL A 236
GLY A 222
ILE A 212
None
0.94A 3oxvC-1v5fA:
undetectable
3oxvC-1v5fA:
10.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OXV_C_478C200_2
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 11 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.93A 3oxvD-1v5fA:
undetectable
3oxvD-1v5fA:
10.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OXW_B_017B200_2
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 10 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.94A 3oxwB-1v5fA:
undetectable
3oxwB-1v5fA:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OXW_D_017D200_2
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 10 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.97A 3oxwD-1v5fA:
undetectable
3oxwD-1v5fA:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OXW_D_017D200_2
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 10 LEU A 276
ALA A 214
VAL A 236
GLY A 222
ILE A 212
None
0.95A 3oxwD-1v5fA:
undetectable
3oxwD-1v5fA:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OY4_B_017B200_1
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 11 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.89A 3oy4A-1v5fA:
undetectable
3oy4A-1v5fA:
10.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PWM_B_017B402_1
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.95A 3pwmA-1v5fA:
undetectable
3pwmA-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PWM_B_017B402_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.94A 3pwmB-1v5fA:
undetectable
3pwmB-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PWR_A_ROCA401_3
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.88A 3pwrB-1v5fA:
undetectable
3pwrB-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QL3_A_FOLA161_0
(DIHYDROFOLATE
REDUCTASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ILE A 300
ALA A 214
LEU A 228
ILE A 298
THR A 218
None
1.23A 3ql3A-1v5fA:
undetectable
3ql3A-1v5fA:
16.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TKG_C_ROCC901_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
1.00A 3tkgD-1v5fA:
undetectable
3tkgD-1v5fA:
11.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TKW_B_017B401_1
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.95A 3tkwA-1v5fA:
undetectable
3tkwA-1v5fA:
11.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WDM_B_ADNB301_1
(4-PHOSPHOPANTOATE--B
ETA-ALANINE LIGASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 10 ALA A 200
LEU A 228
LEU A 276
ASN A 296
ILE A 212
None
1.01A 3wdmB-1v5fA:
9.6
3wdmB-1v5fA:
19.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WDM_C_ADNC301_1
(4-PHOSPHOPANTOATE--B
ETA-ALANINE LIGASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 9 ALA A 200
LEU A 228
LEU A 276
ASN A 296
ILE A 212
None
1.05A 3wdmC-1v5fA:
9.7
3wdmC-1v5fA:
19.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DQB_B_017B101_1
(ASPARTYL PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.92A 4dqbA-1v5fA:
undetectable
4dqbA-1v5fA:
10.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DQC_A_017A101_1
(ASPARTYL PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 10 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.92A 4dqcA-1v5fA:
undetectable
4dqcA-1v5fA:
10.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DQC_A_017A101_2
(ASPARTYL PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 9 GLY A 390
ASP A 442
VAL A 466
GLY A 418
ILE A 419
TPP  A1602 ( 3.9A)
MG  A1603 ( 2.8A)
None
None
None
1.07A 4dqcB-1v5fA:
undetectable
4dqcB-1v5fA:
10.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DQE_B_017B101_1
(ASPARTYL PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 11 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.93A 4dqeA-1v5fA:
undetectable
4dqeA-1v5fA:
10.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DQH_B_017B101_1
(WILD-TYPE HIV-1
PROTEASE DIMER)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 11 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.92A 4dqhA-1v5fA:
undetectable
4dqhA-1v5fA:
10.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EAH_F_ACTF402_0
(ACTIN, ALPHA
SKELETAL MUSCLE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
3 / 3 PHE A 508
ASP A 515
ARG A 518
None
0.86A 4eahF-1v5fA:
undetectable
4eahF-1v5fA:
22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EAH_G_ACTG401_0
(ACTIN, ALPHA
SKELETAL MUSCLE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
3 / 3 PHE A 508
ASP A 515
ARG A 518
None
0.86A 4eahG-1v5fA:
undetectable
4eahG-1v5fA:
22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JEC_B_478B401_2
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.85A 4jecB-1v5fA:
undetectable
4jecB-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LL3_A_017A201_1
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 8 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
1.00A 4ll3A-1v5fA:
undetectable
4ll3A-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LL3_A_017A202_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 9 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.97A 4ll3B-1v5fA:
undetectable
4ll3B-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NJT_B_017B101_1
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 11 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.92A 4njtA-1v5fA:
undetectable
4njtA-1v5fA:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NJT_D_017D101_1
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 11 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.90A 4njtC-1v5fA:
undetectable
4njtC-1v5fA:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NJU_A_TPVA500_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 10 LEU A 276
ALA A 214
VAL A 236
GLY A 222
ILE A 212
None
0.91A 4njuB-1v5fA:
undetectable
4njuB-1v5fA:
10.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NJV_A_RITA500_1
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.82A 4njvA-1v5fA:
undetectable
4njvA-1v5fA:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NJV_A_RITA500_1
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 GLY A 390
ASP A 442
VAL A 466
GLY A 418
ILE A 419
TPP  A1602 ( 3.9A)
MG  A1603 ( 2.8A)
None
None
None
0.95A 4njvA-1v5fA:
undetectable
4njvA-1v5fA:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NJV_A_RITA500_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 11 GLY A 390
ASP A 442
VAL A 466
GLY A 418
ILE A 419
TPP  A1602 ( 3.9A)
MG  A1603 ( 2.8A)
None
None
None
1.01A 4njvB-1v5fA:
undetectable
4njvB-1v5fA:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NJV_D_RITD500_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.84A 4njvD-1v5fA:
undetectable
4njvD-1v5fA:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NJV_D_RITD500_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 GLY A 390
ASP A 442
VAL A 466
GLY A 418
ILE A 419
TPP  A1602 ( 3.9A)
MG  A1603 ( 2.8A)
None
None
None
0.94A 4njvD-1v5fA:
undetectable
4njvD-1v5fA:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4P66_A_MTXA201_1
(DIHYDROFOLATE
REDUCTASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 11 ILE A 300
ALA A 214
LEU A 204
ILE A 298
THR A 218
None
1.19A 4p66A-1v5fA:
undetectable
4p66A-1v5fA:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4P7N_A_GCSA702_1
(POLY-BETA-1,6-N-ACET
YL-D-GLUCOSAMINE
N-DEACETYLASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
3 / 3 ASP A 146
TYR A 178
TRP A  19
None
1.09A 4p7nA-1v5fA:
undetectable
4p7nA-1v5fA:
21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PO0_A_NPSA601_1
(SERUM ALBUMIN)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASN A 344
PHE A 577
LEU A 581
VAL A 211
SER A 338
None
1.38A 4po0A-1v5fA:
undetectable
4po0A-1v5fA:
22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QGI_A_ROCA101_2
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 11 LEU A 276
ALA A 214
VAL A 236
GLY A 222
ILE A 212
None
0.88A 4qgiB-1v5fA:
undetectable
4qgiB-1v5fA:
10.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R29_C_SAMC301_0
(UNCHARACTERIZED
PROTEIN)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ARG A 150
ALA A 181
SER A  18
GLY A  20
ALA A 159
None
1.09A 4r29C-1v5fA:
undetectable
4r29C-1v5fA:
16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RVJ_B_478B101_2
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 9 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.92A 4rvjB-1v5fA:
undetectable
4rvjB-1v5fA:
10.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RVJ_D_478D101_2
(HIV-1 PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 9 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.92A 4rvjD-1v5fA:
undetectable
4rvjD-1v5fA:
10.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4W5T_A_IPHA903_0
(PROTEIN ARGONAUTE-2)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
4 / 5 TYR A 178
LYS A 143
PRO A 142
GLU A 147
None
1.39A 4w5tA-1v5fA:
2.0
4w5tA-1v5fA:
20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Z4C_A_IPHA904_0
(PROTEIN ARGONAUTE-2)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
4 / 6 TYR A 178
LYS A 143
PRO A 142
GLU A 147
None
1.41A 4z4cA-1v5fA:
4.4
4z4cA-1v5fA:
20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FSA_A_X2NA590_2
(CYP51 VARIANT1)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
3 / 3 PRO A 544
ILE A 348
SER A 392
None
None
TPP  A1602 (-2.7A)
0.78A 5fsaA-1v5fA:
undetectable
5fsaA-1v5fA:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5H5F_A_SAMA301_1
(PROTEIN ARGININE
N-METHYLTRANSFERASE
SFM1)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
4 / 5 GLY A 215
PRO A 404
THR A 218
THR A 239
FAD  A1601 (-2.9A)
None
None
FAD  A1601 (-2.8A)
1.07A 5h5fA-1v5fA:
undetectable
5h5fA-1v5fA:
18.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KB6_A_ADNA401_1
(ADENOSINE KINASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 GLY A 222
ALA A 214
GLY A 215
ALA A 278
ILE A 212
None
None
FAD  A1601 (-2.9A)
None
None
0.91A 5kb6A-1v5fA:
3.0
5kb6A-1v5fA:
22.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KB6_B_ADNB401_1
(ADENOSINE KINASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 GLY A 222
ALA A 214
GLY A 215
ALA A 278
ILE A 212
None
None
FAD  A1601 (-2.9A)
None
None
0.92A 5kb6B-1v5fA:
undetectable
5kb6B-1v5fA:
22.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KR0_A_478A101_2
(PROTEASE E35D-APV)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 9 GLY A 390
ASP A 442
VAL A 466
GLY A 418
ILE A 419
TPP  A1602 ( 3.9A)
MG  A1603 ( 2.8A)
None
None
None
1.05A 5kr0B-1v5fA:
undetectable
5kr0B-1v5fA:
10.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5M0O_C_EPAC502_1
(TERMINAL
OLEFIN-FORMING FATTY
ACID DECARBOXYLASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
4 / 8 ILE A 237
PHE A 282
ALA A 265
PRO A 412
None
FAD  A1601 (-4.1A)
None
FAD  A1601 (-4.0A)
0.82A 5m0oC-1v5fA:
undetectable
5m0oC-1v5fA:
22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5T2Z_B_017B201_1
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
1.02A 5t2zA-1v5fA:
undetectable
5t2zA-1v5fA:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VLM_F_CVIF301_1
(REGULATORY PROTEIN
TETR)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
4 / 8 ILE A 397
TYR A 369
TRP A 351
VAL A 547
None
1.05A 5vlmF-1v5fA:
0.0
5vlmF-1v5fA:
15.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWO_A_SREA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 9 ASP A  95
ALA A 129
PHE A 414
GLY A  88
GLY A 157
None
1.35A 6awoA-1v5fA:
undetectable
6awoA-1v5fA:
21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWQ_A_SREA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 9 ASP A  95
ALA A 129
PHE A 414
GLY A  88
GLY A 157
None
1.35A 6awqA-1v5fA:
undetectable
6awqA-1v5fA:
21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BQ4_A_ADNA401_1
(THERMOSPERMINE
SYNTHASE ACAULIS
PROTEIN)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
6 / 12 GLY A 279
ASP A 301
ILE A 302
ASP A 303
ASP A 320
ALA A 321
FAD  A1601 (-3.5A)
FAD  A1601 (-3.0A)
FAD  A1601 (-3.9A)
None
FAD  A1601 (-3.8A)
FAD  A1601 (-3.5A)
0.68A 6bq4A-1v5fA:
3.8
6bq4A-1v5fA:
8.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BQ4_B_ADNB401_1
(THERMOSPERMINE
SYNTHASE ACAULIS
PROTEIN)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
6 / 12 GLY A 279
ASP A 301
ILE A 302
ASP A 303
ASP A 320
ALA A 321
FAD  A1601 (-3.5A)
FAD  A1601 (-3.0A)
FAD  A1601 (-3.9A)
None
FAD  A1601 (-3.8A)
FAD  A1601 (-3.5A)
0.71A 6bq4B-1v5fA:
3.7
6bq4B-1v5fA:
8.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DGX_A_017A101_0
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.94A 6dgxA-1v5fA:
undetectable
6dgxA-1v5fA:
8.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DH3_A_017A101_0
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.95A 6dh3A-1v5fA:
undetectable
6dh3A-1v5fA:
8.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DH6_A_017A104_0
(PROTEASE)
1v5f PYRUVATE OXIDASE
(Aerococcus
viridans)
5 / 12 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.93A 6dh6A-1v5fA:
undetectable
6dh6A-1v5fA:
8.56